Asking patients with hematological malignancies: 'how do you feel?' Does it really provide independent prognostic information for survival?

被引：3

|

作者：

Efficace, Fabio ^{[1
]}

Vignetti, Marco ^{[1
]}

Mandelli, Franco ^{[1
]}

机构：

[1] GIMEMA Data Ctr, Italian Grp Adult Hematol Dis GIMEMA, Hlth Outcomes Res Unit, I-00161 Rome, Italy

来源：

EUROPEAN JOURNAL OF HAEMATOLOGY | 2009年 / 82卷 / 06期

关键词：

MULTIPLE-MYELOMA; REPORTED OUTCOMES; CHEMOTHERAPY; CANCER; HEALTH;

D O I：

10.1111/j.1600-0609.2009.01254.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：484 / 485

页数：2

相关论文

共 3 条

[1] 'When something is this rare ... how do you know bad really is bad ... ?'-views on prognostic discussions from patients with advanced soft tissue sarcoma
Gough, Nicholas
Ross, Joy R.
Riley, Julia
Judson, Ian
Koffman, Jonathan
BMJ SUPPORTIVE & PALLIATIVE CARE, 2019, 9 (01) : 100 - 107
[2] ASO Author Reflections: What are the Prognostic Factors for Achieving Long-Term Survival in MPM Patients Treated with CRS plus HIPEC? Does the Conditional Survival Analysis Provide Special Information?
Liang, Xin-Li
Li, Yan
ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (04) : 2936 - 2937
[3] How do you provide security for HIV test results? Are results available on the patient's chart or in the laboratory information system (LIS) or hospital information system (HIS)? Are patients registered using their names or is anonymous testing performed?
Alexander, TS
LABORATORY MEDICINE, 1999, 30 (02) : 94 - 94